FDA recalls Gilead's COVID drug Veklury due to glass particles as 21 states show "very high" virus levels in wastewater ...

Health authorities have said that stockpiled Tamiflu should work well against H5N1. Some experts question that bet.

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population, ...

In terms of how quickly they alleviate symptoms, oseltamivir and baloxavir are on par, said Yen. But baloxavir is better at ...

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the ...

Roche Holdings AG (OTC:RHHBY) released positive topline results of the phase 3 CENTERSTONE study of Xofluza (baloxavir ...

Roche RHHBY announced positive top-line results from a late-study on influenza drug, Xofluza. The CENTERSTONE study was a global phase III trial investigating the efficacy of single-dose Xofluza, ...

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population found ...

Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the "Disease Prevention and Control Summit ...

Xofluza was well tolerated with no new safety signals identified. Every year, seasonal influenza infects an estimated one billion people and causes up to 650,000 deaths globally. On Thursday ...

Assembly Biosciences reported interim results from its Phase 1a study of ABI-5366, a long-acting HSV inhibitor for recurrent ...

The drug was well tolerated with no new safety signal identified. Per Roche, this study is the first global phase III study to show a transmission reduction benefit with an antiviral used in the ...